Sun Pharma Advanced Research Company Ltd. — Call Transcript 2022

Sep 29, 2022

SPARC/Sec/SE/2022-23/056

September 29, 2022

National Stock Exchange of India Ltd., BSE Limited, Exchange Plaza, 5th Floor, Market Operations Dept. Plot No. C/1, G Block, P. J. Towers, Bandra Kurla Complex, Dalal Street, Bandra (East), Mumbai – 400 051. Mumbai - 400 001.

Ref: Scrip Code: NSE: SPARC; BSE: 532872

Dear Sir/Madam,

Sub: Press Release: SPARC to provide Update on Clinical Programs and R&D Pipeline

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the Press Release on the above mentioned subject being released by the Company, which is self-explanatory.

This is for your information and dissemination.

Yours faithfully,

For Sun Pharma Advanced Research Company Ltd.

Digitally signed by DINESH POOSRAJ LAHOTI DINESH DN: c=IN, o=PERSONAL, title=3569, pseudonym=e06989b3aebf5d3091 c446300899af58210fb58fc8685d70 833cc08580f0eea2, POOSRA postalCode=401101, st=Maharashtra, serialNumber=2dbd91f7a8b4b648 333501ef1daa3ec5d1c5bd522372e J LAHOTI fc92b45995ad83eeb86, cn=DINESH POOSRAJ LAHOTI Date: 2022.09.29 10:03:32 +05'30'

Dinesh Lahoti Company Secretary and Compliance Officer ICSI Membership No. A22471

Encl: As above

==> picture [595 x 109] intentionally omitted <==

FOR IMMEDIATE RELEASE

SPARC to Provide Update on Clinical Programs and R&D Pipeline

MUMBAI – September 29, 2022 , Sun Pharma Advanced Research Company Ltd. (SPARC) (Reuters: SPRC.BO, Bloomberg: SPADV IN, NSE: SPARC, BSE: 532872) on Thursday, October 13, 2022, will host a Management Presentation over an audio conference to share and provide an update on its clinical programs and R&D pipeline. This conference call, scheduled at 4:00 PM IST, will be reachable through an audio dial-in.

Audio conference

Participants can dial-in on the number below:

Universal Dial In +91 22 6280 1278 +91 22 7115 8179 India National Toll Free 1 800 120 1221 International Toll Free Hong Kong 800964448 Singapore 8001012045 UK 08081011573 USA 18667462133

Management presentation: The presentation pertaining to this discussion can be accessed through the link given below on the date of audio conference.

https://links.ccwebcast.com/?EventId=SPA221013

To participate in the conference call, please dial in the number provided above couple of minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call.

About SPARC (CIN: L73100GJ2006PLC047837):

Sun Pharma Advanced Research Company Ltd. (SPARC) is a pharmaceutical company focused on continuously improving standards of care for patients globally through innovation in therapeutics and delivery. SPARC consistently aims to lower costs and improve operational efficiencies to advance availability and affordability of cures for patients across the world. More information about the company can be found at www.sparc.life

Media Contact: Jaydeep Issrani Tel +91 22 66455645, Ext: 5787 Tel Direct +91 22 6645 5787 Mobile +91-9820216916 E-mail jaydeep.issrani@sparcmail.com

®, TM - All brand names and trademarks are the property of respective owners.